PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 5.35

Change

-0.20 (-3.60)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.24 (-1.81%)

USD 8.14B
QLD ProShares Ultra QQQ

-1.10 (-1.18%)

USD 5.50B
SSO ProShares Ultra S&P500

-0.90 (-1.09%)

USD 4.33B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 4.29B
UPRO ProShares UltraPro S&P500

-1.18 (-1.64%)

USD 2.91B
TECL Direxion Daily Technology Bull..

-0.96 (-1.59%)

USD 1.95B
YINN Direxion Daily FTSE China Bull..

-0.03 (-0.09%)

USD 1.19B
USD ProShares Ultra Semiconductors

-0.52 (-1.24%)

USD 0.61B
UDOW ProShares UltraPro Dow30

-0.45 (-0.57%)

USD 0.56B
LABU Direxion Daily S&P Biotech Bul..

-1.76 (-2.86%)

USD 0.53B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -24.65% 25% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.65% 25% F 9% A-
Trailing 12 Months  
Capital Gain -20.27% 30% F 17% F
Dividend Return 0.76% 55% F 14% F
Total Return -19.51% 31% F 15% F
Trailing 5 Years  
Capital Gain -63.85% 6% D- 5% F
Dividend Return 1.89% 10% F 4% F
Total Return -61.96% 6% D- 5% F
Average Annual (5 Year Horizon)  
Capital Gain 51.49% 88% B+ 95% A
Dividend Return 52.12% 88% B+ 95% A
Total Return 0.62% 42% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 392.93% 7% C- 3% F
Risk Adjusted Return 13.26% 26% F 32% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.